F18.92 Inhalant use, unspecified with intoxication

Name of the Condition

• Common Name: Inhalant Use Disorder with Intoxication
• Medical Term: Inhalant Use, Unspecified with Intoxication

Summary

Inhalant use, unspecified with intoxication, refers to the misuse of inhalants—substances that produce chemical vapors—for their psychoactive effects, accompanied by acute intoxication. This condition involves the intentional inhalation of substances like glue, paint thinners, or aerosols, which can lead to immediate physical and psychological effects. Inhalant use may result in significant harm, affecting an individual's health and daily functioning.

Causes

Inhalant use is primarily driven by the repeated misuse of inhalants for their psychoactive effects. Inhalants are often everyday household or industrial products, such as glue, paint thinners, aerosols, or solvents. The misuse of these substances can lead to dependence and related health issues.

Risk Factors

• Adolescents and young adults are more likely to experiment with inhalants.
• Individuals with a history of substance abuse or mental health disorders.
• Accessibility to inhalant products.
• Lack of proper supervision or guidance.

Symptoms

• Intense cravings or compulsive inhalant use.
• Coordination problems, dizziness, or lethargy.
• Unexplained behavioral changes such as aggression or mood swings.
• Cognitive impairment.

Diagnosis

Diagnosis involves a clinical evaluation, including a detailed history of substance use, physical examination, and assessment of symptoms. Laboratory tests may be used to rule out other conditions, and criteria from diagnostic manuals (e.g., DSM-5) are applied to confirm the presence of intoxication.

Treatment Options

Treatment may include detoxification, behavioral therapy, and support groups. Medications may be used to manage withdrawal symptoms or co-occurring conditions. Long-term care often involves addressing underlying issues and promoting abstinence.

Prognosis and Follow-Up

Prognosis depends on the severity of use, presence of co-occurring disorders, and adherence to treatment. Regular follow-up is essential to monitor progress, prevent relapse, and address any emerging complications.

Complications

• Respiratory distress or failure.
• Neurological damage.
• Organ damage (e.g., liver, kidneys).
• Increased risk of accidents or injuries.

Lifestyle & Prevention

• Avoiding exposure to inhalant products.
• Educating at-risk populations about the dangers of inhalant use.
• Promoting healthy coping mechanisms and stress management.
• Ensuring proper supervision of children and adolescents.

When to Seek Professional Help

Seek help if experiencing persistent cravings, difficulty stopping use, or signs of intoxication. Immediate medical attention is needed for severe symptoms like respiratory distress or loss of consciousness.

Tips for Medical Coders

Document the presence of intoxication and any associated symptoms to support the use of F18.92. Ensure clinical documentation aligns with the criteria for inhalant use and intoxication, including details on substance type and acute effects.